(Q42601462)

3 November 2017

title

Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients (English)

1 reference

3 November 2017

1 reference

Carlos Pérez-Ruixo

1

1 reference

3 November 2017

Belén Valenzuela

2

1 reference

3 November 2017

Carlos Fernández Teruel

3

1 reference

3 November 2017

Mario González-Sales

4

1 reference

3 November 2017

Bernardo Miguel-Lillo

5

1 reference

3 November 2017

Arturo Soto-Matos

6

1 reference

3 November 2017

Juan José Pérez-Ruixo

7

1 reference

3 November 2017

publication date

18 May 2011

1 reference

Cancer Chemotherapy and Pharmacology

3 November 2017

published in

1 reference

3 November 2017

volume

69

1 reference

3 November 2017

issue

1

1 reference

3 November 2017

page(s)

15-24

1 reference

Molecular pharmacology and antitumor activity of Zalypsis in several human cancer cell lines

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM00104, a novel antineoplastic agent, in mouse, rat, dog, and human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1644-6

10.1007/S00280-011-1644-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 November 2017

1003635249

0 references

1 reference